Literature DB >> 11414557

Using weighted Kaplan-Meier statistics in nonparametric comparisons of paired censored survival outcomes.

S Murray1.   

Abstract

This research introduces methods for nonparametric testing of weighted integrated survival differences in the context of paired censored survival designs. The current work extends work done by Pepe and Fleming (1989, Biometrics 45, 497-507), which considered similar test statistics directed toward independent treatment group comparisons. An asymptotic closed-form distribution of the proposed family of tests is presented, along with variance estimates constructed under null and alternative hypotheses using nonparametric maximum likelihood estimates of the closed-form quantities. The described method allows for additional information from individuals with no corresponding matched pair member to be incorporated into the test statistic in sampling scenarios where singletons are not prone to selection bias. Simulations presented over a range of potential dependence in the paired censored survival data demonstrate substantial power gains associated with taking into account the dependence structure. Consequences of ignoring the paired nature of the data include overly conservative tests in terms of power and size. In fact, simulation results using tests for independent samples in the presence of positive correlation consistently undershot both size and power targets that would have been attained in the absence of correlation. This additional worrisome effect on operating characteristics highlights the need for accounting for dependence in this popular family of tests.

Entities:  

Mesh:

Year:  2001        PMID: 11414557     DOI: 10.1111/j.0006-341x.2001.00361.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

1.  Sample size determination for paired right-censored data based on the difference of Kaplan-Meier estimates.

Authors:  Pei-Fang Su; Chung-I Li; Yu Shyr
Journal:  Comput Stat Data Anal       Date:  2014-06-01       Impact factor: 1.681

2.  Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.

Authors:  Lihui Zhao; Lu Tian; Hajime Uno; Scott D Solomon; Marc A Pfeffer; Jerald S Schindler; Lee Jen Wei
Journal:  Clin Trials       Date:  2012-08-22       Impact factor: 2.486

3.  Comparing conditional survival functions with missing population marks in a competing risks model.

Authors:  Dipankar Bandyopadhyay; M Amalia Jácome
Journal:  Comput Stat Data Anal       Date:  2016-03-01       Impact factor: 1.681

4.  Analyzing survival curves at a fixed point in time for paired and clustered right-censored data.

Authors:  Pei-Fang Su; Yunchan Chi; Chun-Yi Lee; Yu Shyr; Yi-De Liao
Journal:  Comput Stat Data Anal       Date:  2010-10-21       Impact factor: 1.681

5.  A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.

Authors:  Edward M Kerwin; Selwyn Spangenthal; Christine Kollar; Earl St Rose; Colin Reisner
Journal:  Respir Res       Date:  2018-03-05

6.  Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD.

Authors:  Colin Reisner; James Pearle; Edward M Kerwin; Earl St Rose; Patrick Darken
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.